Cell & Gene Therapy Trends in 2025: A Year of Reset, Rebalancing, and Renewed Momentum
Alain Pralong1,3 Renaud Jacquemart2,3 Katrina Cordovado2,3 Pharma Consulting ENABLE GmbH Omnium Global Consulting Inc. ENABLE Biotech AG 2025 has certainly been a dynamic year for the cell and gene therapy (CGT) industry. Following several years of rapid expansion, the sector entered a period of recalibration marked by CDMO restructuring, more selective investment behavior, and a renewed emphasis […]